SamanTree Medical Achieves FDA Clearance for Histolog® Scanner, Ushering in a New Era of Tissue Imaging in the U.S. 
Liège, Belgium and Lausanne, Switzerland - September 13th, 2024

New generation ultra-fast fluorescence confocal microscopy (UFCM) allows to image histological architecture of fresh breast tissue and may be used for ex vivo intraoperative analysis for margin status. The criteria to identify breast tumoral and non-tumoral tissues in UFCM images are still objects of investigation.

Olivier Delporte joins SamanTree Medical with a proven track record of leadership in the medical technology industry. With over 22 years of experience driving growth and innovation of fast-growing companies across various therapeutic areas, Olivier is poised to lead the company towards new heights of success.

LAUSANNE, Switzerland, SamanTree Medical, a medical technology company driven to support clinicians with their intraoperative decisions and improve cancer surgery outcomes, announced today the publication of clinical data in prostate cancer, expanding the potential clinical utility of its proprietary medical imaging platform, the Histolog Scanner.

SamanTree Medical, a medical technology company driven to support clinicians with their intraoperative decisions and improve cancer surgery outcomes, announced today the publication of clinical data unraveling the potential of its proprietary medical imaging platform, the Histolog® Scanner.

SamanTree Medical is proud to announce the obtention of ISO 13485:2016 from the British Standards Institution (BSI).

In 2020, SamanTree Medical has teamed up with leading experts in Germany

The Histolog® Scanner emerged victorious from the 2020 edition of the Red Dot Product Design Award. Not once, but twice! Its outstanding design indeed got the Histolog® Scanner rewarded in the following categories:

Following the promising clinical results achieved with its CE mark device, SamanTree Medical has recently closed a CHF 9.5 Million Series A financing round for developing its commercial operations.

Latest version of the Histolog™ Scanner obtained the CE Mark for compliance with European Directives. The product has been upgraded to suit the specific needs of the breast cancer surgery.

European Innovation Council of the European Union supports Histolog™ Scanner market entry with €2.3 millions grant, via its H2020 SME’s Instrument program.

SamanTree Medical has been granted a loan of CHF 400’000 by the Foundation for Technological Innovation (FIT) to support the Histolog Scanner market entry.

The prestigious PERL competition rewards SamanTree Medical for its Histolog™ Scanner, a breakthrough imaging modality offering a direct support during cancer surgery to improve patient quality of life by decreasing rates of reoperation.

What if you could bring high quality microscopy to the operating room?

The Histolog Scanner has been presented during a poster session at the yearly congress of the German Society of Dermatology (Deutsche Dermatologische Gesellschaft).